The global Assisted Reproductive Technology (ART) market size was valued at US$ 19620 million in 2023. With growing demand in downstream market, the Assisted Reproductive Technology (ART) is forecast to a readjusted size of US$ 29270 million by 2030 with a CAGR of 5.9% during review period.
The research report highlights the growth potential of the global Assisted Reproductive Technology (ART) market. Assisted Reproductive Technology (ART) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Assisted Reproductive Technology (ART). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Assisted Reproductive Technology (ART) market.
Assisted Reproductive Technology (ART) is the technology used to achieve pregnancy in procedures such as fertility medication, in vitro fertilization and surrogacy. It is reproductive technology used primarily for infertility treatments, and is also known as fertility treatment. It mainly belongs to the field of reproductive endocrinology and infertility, and may also include intracytoplasmic sperm injection (ICSI) and cryopreservation. Some forms of ART are also used with regard to fertile couples for genetic reasons (preimplantation genetic diagnosis). ART is also used for couples who are discordant for certain communicable diseases; for example, HIV to reduce the risk of infection when a pregnancy is desired.
North America is also expected to witness growth in the coming years. This is due to people awareness towards various fertility options, government support for the in-vitro fertilization and various technological and procedure up gradation. For instance, in August 2015 Ovascience鈥檚 treatment named AUGMENT has been reported to have rejuvenated women鈥檚 aging egg cells and provided benefits to eggs with poor quality. In February 2015, the scientist of U.S. who invented the three parent IVF procedure requested the Food and Drug Administration (FDA) to grant permission for its clinical trials as age related infertility.
Key Features:
The report on Assisted Reproductive Technology (ART) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Assisted Reproductive Technology (ART) market. It may include historical data, market segmentation by Type (e.g., In-Vitro Fertilization (IVF), Artificial Insemination (AI)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Assisted Reproductive Technology (ART) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Assisted Reproductive Technology (ART) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Assisted Reproductive Technology (ART) industry. This include advancements in Assisted Reproductive Technology (ART) technology, Assisted Reproductive Technology (ART) new entrants, Assisted Reproductive Technology (ART) new investment, and other innovations that are shaping the future of Assisted Reproductive Technology (ART).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Assisted Reproductive Technology (ART) market. It includes factors influencing customer ' purchasing decisions, preferences for Assisted Reproductive Technology (ART) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Assisted Reproductive Technology (ART) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Assisted Reproductive Technology (ART) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Assisted Reproductive Technology (ART) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Assisted Reproductive Technology (ART) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Assisted Reproductive Technology (ART) market.
Market Segmentation:
Assisted Reproductive Technology (ART) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
In-Vitro Fertilization (IVF)
Artificial Insemination (AI)
Segmentation by application
Women Younger Than Age 35
Women Older Than Age 35
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Irvine Scientific
Origio a/s
Vitro Life
Esco Micro Pte. Ltd.
IVFtech ApS
Research Instruments
Genea Limited
Smiths Medical
Thermo Fisher Scientific, Inc.
Cook Medical
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Assisted Reproductive Technology (ART) Market Size 2019-2030
2.1.2 Assisted Reproductive Technology (ART) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Assisted Reproductive Technology (ART) Segment by Type
2.2.1 In-Vitro Fertilization (IVF)
2.2.2 Artificial Insemination (AI)
2.3 Assisted Reproductive Technology (ART) Market Size by Type
2.3.1 Assisted Reproductive Technology (ART) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Assisted Reproductive Technology (ART) Market Size Market Share by Type (2019-2024)
2.4 Assisted Reproductive Technology (ART) Segment by Application
2.4.1 Women Younger Than Age 35
2.4.2 Women Older Than Age 35
2.5 Assisted Reproductive Technology (ART) Market Size by Application
2.5.1 Assisted Reproductive Technology (ART) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Assisted Reproductive Technology (ART) Market Size Market Share by Application (2019-2024)
3 Assisted Reproductive Technology (ART) Market Size by Player
3.1 Assisted Reproductive Technology (ART) Market Size Market Share by Players
3.1.1 Global Assisted Reproductive Technology (ART) Revenue by Players (2019-2024)
3.1.2 Global Assisted Reproductive Technology (ART) Revenue Market Share by Players (2019-2024)
3.2 Global Assisted Reproductive Technology (ART) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Assisted Reproductive Technology (ART) by Regions
4.1 Assisted Reproductive Technology (ART) Market Size by Regions (2019-2024)
4.2 Americas Assisted Reproductive Technology (ART) Market Size Growth (2019-2024)
4.3 APAC Assisted Reproductive Technology (ART) Market Size Growth (2019-2024)
4.4 Europe Assisted Reproductive Technology (ART) Market Size Growth (2019-2024)
4.5 Middle East & Africa Assisted Reproductive Technology (ART) Market Size Growth (2019-2024)
5 Americas
5.1 Americas Assisted Reproductive Technology (ART) Market Size by Country (2019-2024)
5.2 Americas Assisted Reproductive Technology (ART) Market Size by Type (2019-2024)
5.3 Americas Assisted Reproductive Technology (ART) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Assisted Reproductive Technology (ART) Market Size by Region (2019-2024)
6.2 APAC Assisted Reproductive Technology (ART) Market Size by Type (2019-2024)
6.3 APAC Assisted Reproductive Technology (ART) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Assisted Reproductive Technology (ART) by Country (2019-2024)
7.2 Europe Assisted Reproductive Technology (ART) Market Size by Type (2019-2024)
7.3 Europe Assisted Reproductive Technology (ART) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Assisted Reproductive Technology (ART) by Region (2019-2024)
8.2 Middle East & Africa Assisted Reproductive Technology (ART) Market Size by Type (2019-2024)
8.3 Middle East & Africa Assisted Reproductive Technology (ART) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Assisted Reproductive Technology (ART) Market Forecast
10.1 Global Assisted Reproductive Technology (ART) Forecast by Regions (2025-2030)
10.1.1 Global Assisted Reproductive Technology (ART) Forecast by Regions (2025-2030)
10.1.2 Americas Assisted Reproductive Technology (ART) Forecast
10.1.3 APAC Assisted Reproductive Technology (ART) Forecast
10.1.4 Europe Assisted Reproductive Technology (ART) Forecast
10.1.5 Middle East & Africa Assisted Reproductive Technology (ART) Forecast
10.2 Americas Assisted Reproductive Technology (ART) Forecast by Country (2025-2030)
10.2.1 United States Assisted Reproductive Technology (ART) Market Forecast
10.2.2 Canada Assisted Reproductive Technology (ART) Market Forecast
10.2.3 Mexico Assisted Reproductive Technology (ART) Market Forecast
10.2.4 Brazil Assisted Reproductive Technology (ART) Market Forecast
10.3 APAC Assisted Reproductive Technology (ART) Forecast by Region (2025-2030)
10.3.1 China Assisted Reproductive Technology (ART) Market Forecast
10.3.2 Japan Assisted Reproductive Technology (ART) Market Forecast
10.3.3 Korea Assisted Reproductive Technology (ART) Market Forecast
10.3.4 Southeast Asia Assisted Reproductive Technology (ART) Market Forecast
10.3.5 India Assisted Reproductive Technology (ART) Market Forecast
10.3.6 Australia Assisted Reproductive Technology (ART) Market Forecast
10.4 Europe Assisted Reproductive Technology (ART) Forecast by Country (2025-2030)
10.4.1 Germany Assisted Reproductive Technology (ART) Market Forecast
10.4.2 France Assisted Reproductive Technology (ART) Market Forecast
10.4.3 UK Assisted Reproductive Technology (ART) Market Forecast
10.4.4 Italy Assisted Reproductive Technology (ART) Market Forecast
10.4.5 Russia Assisted Reproductive Technology (ART) Market Forecast
10.5 Middle East & Africa Assisted Reproductive Technology (ART) Forecast by Region (2025-2030)
10.5.1 Egypt Assisted Reproductive Technology (ART) Market Forecast
10.5.2 South Africa Assisted Reproductive Technology (ART) Market Forecast
10.5.3 Israel Assisted Reproductive Technology (ART) Market Forecast
10.5.4 Turkey Assisted Reproductive Technology (ART) Market Forecast
10.5.5 GCC Countries Assisted Reproductive Technology (ART) Market Forecast
10.6 Global Assisted Reproductive Technology (ART) Forecast by Type (2025-2030)
10.7 Global Assisted Reproductive Technology (ART) Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Irvine Scientific
11.1.1 Irvine Scientific Company Information
11.1.2 Irvine Scientific Assisted Reproductive Technology (ART) Product Offered
11.1.3 Irvine Scientific Assisted Reproductive Technology (ART) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Irvine Scientific Main Business Overview
11.1.5 Irvine Scientific Latest Developments
11.2 Origio a/s
11.2.1 Origio a/s Company Information
11.2.2 Origio a/s Assisted Reproductive Technology (ART) Product Offered
11.2.3 Origio a/s Assisted Reproductive Technology (ART) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Origio a/s Main Business Overview
11.2.5 Origio a/s Latest Developments
11.3 Vitro Life
11.3.1 Vitro Life Company Information
11.3.2 Vitro Life Assisted Reproductive Technology (ART) Product Offered
11.3.3 Vitro Life Assisted Reproductive Technology (ART) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Vitro Life Main Business Overview
11.3.5 Vitro Life Latest Developments
11.4 Esco Micro Pte. Ltd.
11.4.1 Esco Micro Pte. Ltd. Company Information
11.4.2 Esco Micro Pte. Ltd. Assisted Reproductive Technology (ART) Product Offered
11.4.3 Esco Micro Pte. Ltd. Assisted Reproductive Technology (ART) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Esco Micro Pte. Ltd. Main Business Overview
11.4.5 Esco Micro Pte. Ltd. Latest Developments
11.5 IVFtech ApS
11.5.1 IVFtech ApS Company Information
11.5.2 IVFtech ApS Assisted Reproductive Technology (ART) Product Offered
11.5.3 IVFtech ApS Assisted Reproductive Technology (ART) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 IVFtech ApS Main Business Overview
11.5.5 IVFtech ApS Latest Developments
11.6 Research Instruments
11.6.1 Research Instruments Company Information
11.6.2 Research Instruments Assisted Reproductive Technology (ART) Product Offered
11.6.3 Research Instruments Assisted Reproductive Technology (ART) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Research Instruments Main Business Overview
11.6.5 Research Instruments Latest Developments
11.7 Genea Limited
11.7.1 Genea Limited Company Information
11.7.2 Genea Limited Assisted Reproductive Technology (ART) Product Offered
11.7.3 Genea Limited Assisted Reproductive Technology (ART) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Genea Limited Main Business Overview
11.7.5 Genea Limited Latest Developments
11.8 Smiths Medical
11.8.1 Smiths Medical Company Information
11.8.2 Smiths Medical Assisted Reproductive Technology (ART) Product Offered
11.8.3 Smiths Medical Assisted Reproductive Technology (ART) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Smiths Medical Main Business Overview
11.8.5 Smiths Medical Latest Developments
11.9 Thermo Fisher Scientific, Inc.
11.9.1 Thermo Fisher Scientific, Inc. Company Information
11.9.2 Thermo Fisher Scientific, Inc. Assisted Reproductive Technology (ART) Product Offered
11.9.3 Thermo Fisher Scientific, Inc. Assisted Reproductive Technology (ART) Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Thermo Fisher Scientific, Inc. Main Business Overview
11.9.5 Thermo Fisher Scientific, Inc. Latest Developments
11.10 Cook Medical
11.10.1 Cook Medical Company Information
11.10.2 Cook Medical Assisted Reproductive Technology (ART) Product Offered
11.10.3 Cook Medical Assisted Reproductive Technology (ART) Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Cook Medical Main Business Overview
11.10.5 Cook Medical Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
